An investigation on behalf of investors of Derma Sciences Inc (NASDAQ:DSCI) in connection with the proposed takeover was announced and NASDAQ:DSCI stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/19/2017 -- The acquisition of Derma Sciences Inc is udner investigation over potential wrongdoing. The investigation was announced for investors, who currently hold NASDAQ:DSCI shares, concerning whether the takeover of Derma Sciences Inc. by LifeSciences Holdings Corporation is unfair.
Investors who purchased shares of Derma Sciences Inc (NASDAQ:DSCI) and currently hold any of those NASDAQ:DSCI shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Derma Sciences directors breached their fiduciary duties owed to NASDAQ:DSCI investors in connection with the proposed acquisition.
On January 10, 2017, Derma Sciences Inc announced that it has signed an agreement whereby Derma Sciences will be acquired by Integra LifeSciences Holdings Corporation(Nasdaq: IART) for $7.00 per share of common stock in cash, or a total of approximately $204 million, and $32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and $48.00 per share for its Series B Convertible Preferred Stock, reflecting the stated value of such preferred stock in each case.
However, given that at least one analyst has set the high target price for NASDAQ:DSCI shares at $8.50 per share, the investigation concerns whether the offer is unfair to NASDAQ:DSCI stockholders. More specifically, the investigation concerns whether the Derma Sciences Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On January 18, 2017, NASDAQ:DSCI shares closed at $7.00 per share
Those who are current investors in Derma Sciences Inc shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com